Cystic Fibrosis Research Today is a free monthly online journal that collates and summarizes the latest research about Cystic Fibrosis, including details on symptoms, genetics, treatment, information.

Volume 4 (2007), Issue 7 (July)

1. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis.
   J Pediatr, 151(2): 134-9, 139.e1. [Abstract] [Full-text]
2. Endpoints for clinical trials in young children with cystic fibrosis.
   Proc Am Thorac Soc, 4(4): 418-30. [Abstract] [Full-text]
3. Sputum biomarkers of inflammation in cystic fibrosis lung disease.
   Proc Am Thorac Soc, 4(4): 406-17. [Abstract] [Full-text]
4. Mucociliary clearance as an outcome measure for cystic fibrosis clinical research.
   Proc Am Thorac Soc, 4(4): 399-405. [Abstract] [Full-text]
5. Detection of cystic fibrosis transmembrane conductance regulator activity in early-phase clinical trials.
   Proc Am Thorac Soc, 4(4): 387-98. [Abstract] [Full-text]
6. Patient-reported outcomes in cystic fibrosis.
   Proc Am Thorac Soc, 4(4): 378-86. [Abstract] [Full-text]
7. Advancing outcome measures for the new era of drug development in cystic fibrosis.
   Proc Am Thorac Soc, 4(4): 370-7. [Abstract] [Full-text]
8. Use of lung imaging studies as outcome measures for development of new therapies in cystic fibrosis.
   Proc Am Thorac Soc, 4(4): 359-63. [Abstract] [Full-text]
9. United kingdom cystic fibrosis gene therapy consortium multidose trial: the proposed use of computed tomography.
   Proc Am Thorac Soc, 4(4): 355-8. [Abstract] [Full-text]
10. Computed tomography scanning in cystic fibrosis research trials: practical lessons from three clinical trials in the United States.
    Proc Am Thorac Soc, 4(4): 350-4. [Abstract] [Full-text]
11. A critical discussion of computer analysis in medical imaging.
    Proc Am Thorac Soc, 4(4): 347-9. [Abstract] [Full-text]
12. Imaging and clinical trials in cystic fibrosis.
    Proc Am Thorac Soc, 4(4): 343-6. [Abstract] [Full-text]
13. Cystic fibrosis specific computed tomography scoring.
    Proc Am Thorac Soc, 4(4): 338-42. [Abstract] [Full-text]
14. Power considerations for studies of lung function in cystic fibrosis.
    Proc Am Thorac Soc, 4(4): 334-7. [Abstract] [Full-text]
15. Positron emission tomography and computed tomography versus positron emission tomography computed tomography: tools for imaging the lung.
    Proc Am Thorac Soc, 4(4): 328-33. [Abstract] [Full-text]
16. Magnetic resonance imaging of the lung in cystic fibrosis.
    Proc Am Thorac Soc, 4(4): 321-7. [Abstract] [Full-text]
17. Radiation doses and risks in chest computed tomography examinations.
    Proc Am Thorac Soc, 4(4): 316-20. [Abstract] [Full-text]
18. Computed tomography scanning techniques for the evaluation of cystic fibrosis lung disease.
    Proc Am Thorac Soc, 4(4): 310-5. [Abstract] [Full-text]
19. High-resolution computed tomography of the lung in children with cystic fibrosis: technical factors.
    Proc Am Thorac Soc, 4(4): 306-9. [Abstract] [Full-text]
20. Chest radiographs for outcome assessment in cystic fibrosis.
    Proc Am Thorac Soc, 4(4): 302-5. [Abstract] [Full-text]
21. An overview of endpoints for cystic fibrosis clinical trials: one size does not fit all.
    Proc Am Thorac Soc, 4(4): 299-301. [Abstract] [Full-text]

© 2004-2008 Cystic Fibrosis Research Today. All Rights Reserved.